| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |